All Categories
AI in Oncology Clinical Decision Support
Imagine an oncologist stepping out of tumor board and into clinic with a complex case at hand. The patient’s tumor has multip [...]
Journal of Clinical Oncology Publishes Significant Evidence in Advancing...
The validation study shows no evidence of algorithmic bias. The development of the model may help mitigate the risk of racial [...]
NHS hospitals to test AI tool that helps diagnose...
A tool that uses artificial intelligence to help diagnose men with prostate cancer and guide decisions about treatment is to [...]
Melvin L.K. Chua, FRCR, PhD, FASCO, on validation of...
Data presented at the American Society for Radiation Oncology 67th Annual Meeting validated the performance of the ArteraAI P [...]
Artera Unveils Four Presentations at ASTRO 2025 Illustrating its...
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predi [...]
FDA Approves AI Tool to Transform Prostate Cancer Care...
Prostate cancer is one of the most common cancers affecting men in the United States, and it comes with a heavy price tag. Ne [...]
Positioning & Distribution Will Determine the Winning Healthcare AI...
In a crowded healthcare AI market, the winners will be those that control key leverage points — where data is created, workfl [...]
Artera Product Webinar – August 2025
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating prostate cancer. For lower-risk pat [...]